Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients

Indian Journal of Pathology and Microbiology

Volumn 53, Issue 3, 2010, Pages 408-413

  Singh, Deepak Kumar ^a   Rastogi, Archana ^a   Sakhuja, Puja ^a   Gondal, Ranjana ^a   Sarin, Shiv Kumar ^a  

^a G B PANT HOSPITAL   (India)

Author keywords

Alcoholic liver disease; alcoholic steatohepatitis; non alcoholic

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; HYALIN;

ADULT; AGE; AGED; ALCOHOLIC FATTY LIVER; ARTICLE; ASIAN; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BIOCHEMICAL COMPOSITION; CELL DEGENERATION; CELL PROLIFERATION; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATIC DUCT; HUMAN; HUMAN TISSUE; INDIAN; INFLAMMATION; INTRAHEPATIC CHOLESTASIS; LIVER CELL; LIVER FATTY DEGENERATION; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; MALLORY BODY; NONALCOHOLIC FATTY LIVER; PORTAL VEIN; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEX RATIO;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; DIAGNOSIS, DIFFERENTIAL; FATTY LIVER; FEMALE; HUMANS; INDIA; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; YOUNG ADULT;

EID: 77955884636     PISSN: 03774929     EISSN: 09745130     Source Type: Journal    
DOI: 10.4103/0377-4929.68246     Document Type: Article

References (25)

1. Mandez-Sanchez N, Almeda- Valdes P, Uribe M. Alcoholic liver disease. An update. Ann Hepatol 2005;4:32-42.
2. Yip WW, Burt AD. Alcoholic liver disease. Semin Diagn Pathol 2006;23:149-160
3. Lefkowitch JH. Morphology of alcoholic liver disease. Clin Liver Dis 2005;9:37-53.
4. Ludwig J, Viggiano TR, Mc Gill DB, Oh BJ. Nonalcoholic steatohepatitis. Mayo Clin Proc 1980;55:434-438
5. Brunt EM. Nonalcoholic steatohepatitis. Semin Liver Dis 2004;24:3-20.
6. Lelbach WK. Epidemiology of alcoholic liver disease. Prog Liver Dis 1976;5:494-513.
7. Carson K, Washington MK, Treem WR, Clavien PA, Hunt CM. Recurrence of nonalcoholic steatohepatitis in a liver transplant recipient. Liver Transpl Surg 1997;3:174-176
8. Reid AE. Nonalcoholic steatohepatitis. Gastroenterology 2001;121: 710-723
9. Farrell GC. Nonalcoholic steatohepatitis: What is it and why is it important in the Asia Pacific region. J Gastroenterol Hepatol 2003;18:124-138
10. Salaspuro M. Conventional and coming laboratory markers of alcoholism and heavy drinking. Alcoholish Clin Exp Res 1986;10:5S-12S.
11. Sorbi D, Boynton J, Lindor KD. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol 1999;94:1018-1022
12. Bapista A, Bianchi L, de Groote J. Alcoholic liver disease: morphological manifestations. Review by an international group. Lancet 1981;1:707-711
13. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-1449
14. Satapathy SK, Garg S, Chauhan R, Sakhuja P, Malhotra V, Sharma BC, et al. Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2004;99:1946-1952
15. Agarwal SR, Malhotra V, Sakhuja P, Sarin SK. Clinical, biochemical and histological profile of nonalcoholic steatohepatitis. Indian J Gastroenterol 2001;20:183-186
16. De BK, Gangopadhyay S, Dutta D, Baksi SD, Pani A, Ghosh P. Pentoxifylline versus prednisolone for severe alcoholic hepatitis: A randomized controlled trial. World J Gastroenterol 2009;15:1613-1619
17. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional Report of a WHO Consultation. Diabet Med 1998;15:539-543
18. Tazawa Y, Noguchi H, Nishinomiya F, Takada G. Serum alanine aminotransferases activity in obese children. Acta Paediatr 1997;86:238-241
19. Singh DK, Sakhuja P, Malhotra V, Gondal R, Sarin SK. Independent predictors of steatohepatitis and fibrosis in asian Indian patients with non-alcoholic steatohepatitis. Dig Dis Sci 2008;53:1967-1976
20. Sugimoto M, Sadamoto T, Nonaka H. Clinical and pathological differences between alcoholic hepatitis and non-alcoholic steatohepatitis. Nihon Arukoru Yakubutsu Igakkai Zasshi 2003;38:34-45.
21. Gupte P, Amarapurkar D, Agal S, Baijal R, Kulshrestha P, Pramanik S, et al. Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 2004;19:854-858
22. Pinto HC, Baptista A, Camilo ME, Valente A, Saragoça A, de Moura MC. Nonalcoholic steatohepatitis clinicopathologic comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci 1996;41:172-179
23. Morita Y, Ueno T, Sasaki N, Kuhara K, Yoshioka S, Tateishi Y, et al. Comparison of liver histology between patients with non-alcoholic steatohepatitis and patients with alcoholic steatohepatitis in Japan. Alcohol Clin Exp Res 2005;29:277S-81S.
24. Kojima H, Sakurai S, Uemura M, Takekawa T, Morimoto H, Tamagawa Y, et al. Difference and similarity between non-alcoholic steatohepatitis and alcoholic liver disease. Alcohol Clin Exp Res 2005;29:259S-63S.
25. Itoh S, Yougel T, Kawagoe K. Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis. Am J Gastroenterol 1987;82:650-654